Can-Fite Biopharma (CANF) Earnings (2010 - 2025)
Can-Fite Biopharma (CANF) earnings from Sep 30, 2010 to Jun 30, 2025. The TTM Can-Fite Biopharma (CANF) earnings is -$8.80M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Can-Fite Biopharma (CANF) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +19.40% |
| 3 Years TTM | -11.06% |
| 5 Years TTM | -7.41% |
| 10 Years TTM | +6.50% |
| All Time TTM | +4.60% |
Annual Earnings change of Can-Fite Biopharma (CANF)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$9.91M | +25.76% |
| 2024 | -$7.88M | +3.28% |
| 2023 | -$7.63M | -25.49% |
| 2022 | -$10M | -18.67% |
| 2021 | -$13M | -12.81% |
| 2020 | -$14M | +14.42% |
| 2019 | -$13M | +92.09% |
| 2018 | -$6.57M | +32.19% |
| 2017 | -$4.97M | -27.97% |
| 2016 | -$6.90M | +43.75% |
| 2015 | -$4.80M | -21.31% |
| 2014 | -$6.10M | -26.86% |
| 2013 | -$8.34M | +49.73% |
| 2012 | -$5.57M | -16.87% |
| 2011 | -$6.70M | +82.07% |
| 2010 | -$3.68M | N/A |
Comparison Can-Fite Biopharma (CANF) five years earnings CAGR with competitors
Can-Fite Biopharma (CANF) five years earnings CAGR is -7.41%.